Lista de obras -

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

artículo científico publicado en 2016

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

article

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

artículo científico publicado en 2006

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

artículo científico publicado en 2014

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

artículo científico publicado en 2006

Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.

artículo científico publicado en 2015

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

artículo científico publicado en 2015

Characterising HCV specific CD4+ T-cells following viral-vectored vaccination, directly acting anti-virals and spontaneous viral cure

artículo científico publicado en 2020

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane

artículo científico publicado en 2017

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

artículo científico publicado en 2014

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

artículo científico publicado en 2015

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans

artículo científico publicado en 2015

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

artículo científico publicado en 2012

Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses

artículo científico publicado en 2014

Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization

artículo científico publicado en 2013

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes

artículo científico publicado en 2014

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

artículo científico

Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.

artículo científico publicado en 2016

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

artículo científico publicado en 2015

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain

artículo científico publicado en 2014

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines

artículo científico publicado en 2010

Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus

artículo científico publicado en 2008

Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

artículo científico publicado en 2005

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates

artículo científico publicado en 2014

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection

artículo científico publicado en 2012

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

artículo científico publicado en 2016

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

artículo científico publicado en 2012

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

artículo científico publicado en 2010

Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.

artículo científico publicado en 2009

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy

artículo científico publicado en 2017

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans

scientific article published on 01 June 2020

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

artículo científico publicado en 2006

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.

artículo científico publicado en 2017

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

artículo científico publicado en 2015

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

artículo científico publicado en 2012

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.

artículo científico publicado en 2012

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

scientific article published on 12 October 2020

Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral

artículo científico publicado en 2015

Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection

artículo científico publicado en 2005

Prime-boost vectored malaria vaccines: progress and prospects

artículo científico publicado en 2010

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

artículo científico publicado en 2013

Role of IL28B Gene Polymorphism and Cell-Mediated Immunity in Spontaneous Resolution of Acute Hepatitis C ⬇️

artículo científico publicado el 19 de junio de 2013

Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice

artículo científico publicado en 2004

Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.

artículo científico publicado en 2013

Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus

artículo científico publicado en 2012

T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee

artículo científico publicado en 2014

The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection

artículo científico publicado en 2008

Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix

artículo científico publicado en 2017

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

artículo científico publicado en 2013

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species

artículo científico publicado en 2012

Lista de obras de

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Characterising HCV specific CD4+ T-cells following viral-vectored vaccination, directly acting anti-virals and spontaneous viral cure

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses

Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines

Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus

Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates

Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy

MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral

Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection

Prime-boost vectored malaria vaccines: progress and prospects

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

Role of IL28B Gene Polymorphism and Cell-Mediated Immunity in Spontaneous Resolution of Acute Hepatitis C ⬇️

Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice

Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.

Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus

T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee

The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection

Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species